Wikipedia:Articles for deletion/Navicixizumab


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was delete as endorsed WP:PROD. ansh 666 02:09, 16 January 2018 (UTC)

Navicixizumab

 * – ( View AfD View log  Stats )

Rule of thumb for experimental drug notability requires phase II trials. This drug is in phase I clinical trials. Natureium (talk) 20:01, 8 January 2018 (UTC)


 * Userfy per nom. --Tyranitar Man (talk) 20:34, 8 January 2018 (UTC)
 * Note: This discussion has been included in the list of Medicine-related deletion discussions. Baby miss  fortune 02:54, 9 January 2018 (UTC)


 * Delete, Non-notable. Fails WP:PHARM. Still in Phase I trials. --Tyranitar Man (talk) 13:04, 11 January 2018 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.